Lara van der Schoot

All papers authored by Lara van der Schoot

Distributing this paper is prohibited by the publisher

2022 L. S. van der Schoot

, E. M. Baerveldt, W. A. van Enst, S. P. Menting, M. M. B. Seyger

, S. L. Wanders, I. van Ee, A. H. Pieterse, J. M. P. A. van den Reek

, E. M. G. J. de Jong

National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure

Upload

This paper was not found in any repository, but could be made available legally by the author.

Lara S. van der Schoot

, Selma Atalay

, Marisol E. Otero

, Wietske Kievit

, Juul M. P. A. van den Reek

, Elke M. G. J. de Jong

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab

Upload

This paper is made freely available by the publisher.

Lara S. van der Schoot

, Hans J. M. M. Groenewoud

, Marleen M. H. J. van Gelder

, Marisol E. Otero

, W. Peter Arnold

, Maartje A. M. Berends

, Marjolein S. De Bruin‐Weller

, Sharon R. P. Dodemont

, Marloes M. Kleinpenning, Marjolein I. A. Koetsier

, Else N. Kop

, John E. M. Körver

, Astrid L. A. Kuijpers

, Paula P. van Lümig

, Johannes M. Mommers

and 7 other authors

Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry

Download from doi.org

2021 Lara S. van der Schoot

, Juul M. P. A. van den Reek, Lynda Grine, Lisa Schots, Wietske Kievit, Jo L. W. Lambert, Elke M. G. J. de Jong

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study

Download from doi.org

M. E. van Muijen, L. S. van der Schoot

, J. M. P. A. van den Reek, E. M. G. J. de Jong

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide

Upload

L. S. Schoot

, J. M. P. A. Reek

Data‐driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine

Upload

S. Atalay, L. Schoot

, L. Vandermaesen, L. Vugt, M. Eilander, J. Reek, E. Jong

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

Download from doi.org

2020 Marieke E. C. van Winden

, Lara S. van der Schoot

, Mariluz van de L’Isle Arias, Lieke J. van Vugt, Juul M. P. A. van den Reek, Peter C. M. van de Kerkhof, Elke M. G. J. de Jong, Satish F. K. Lubeek

Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults

Upload

2019 L. S. van der Schoot

, J. M. P. A. van den Reek, J. M. M. Groenewoud, M. E. Otero, M. D. Njoo, P. M. Ossenkoppele, J. M. Mommers, M. I. A. Koetsier, M. A. M. Berends, W. P. Arnold, B. Peters, M. P. M. Andriessen, C. W. Den Hengst, A. L. A. Kuijpers, E. M. G. J. de Jong

Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Lara van der Schoot